135 related articles for article (PubMed ID: 25434503)
1. Young age, male sex, and end-stage renal disease with secondary hyperparathyroidism as risk factors for intraoperative hyperkalemia during parathyroidectomy.
Yang YL; Lu HF; Chung KC; Jawan B; Chou FF
J Clin Anesth; 2015 May; 27(3):195-200. PubMed ID: 25434503
[TBL] [Abstract][Full Text] [Related]
2. Clinical predictor of postoperative hyperkalemia after parathyroidectomy in patients with hemodialysis.
Li S; Liu S; Chen Q; Ge P; Jiang J; Sheng X; Chen S
Int J Surg; 2018 May; 53():1-4. PubMed ID: 29548699
[TBL] [Abstract][Full Text] [Related]
3. Risk factors of hyperkalemia after total parathyroidectomy in patients with secondary hyperparathyroidism.
Zou Y; Zhang L; Zhou H; Yang Y; Yang M; Di J
Ren Fail; 2020 Nov; 42(1):1029-1031. PubMed ID: 33028124
[No Abstract] [Full Text] [Related]
4. Intra-operative hyperkalemia: a serious but under recognised complication of renal parathyroidectomy - a prospective study: how we do it.
Bajaj Y; Roberts S; Simon D; Snowden C; Gianopoulos I; England RJ
Clin Otolaryngol; 2011 Feb; 36(1):69-72. PubMed ID: 21414155
[No Abstract] [Full Text] [Related]
5. Can we predict who will develop postoperative hyperkalaemia after parathyroidectomy in dialysis patients with secondary hyperparathyroidism?
Song YH; Cai GY; Xiao YF; Wang YP; Yang ST; Chen XM
BMC Nephrol; 2019 Jun; 20(1):225. PubMed ID: 31221111
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative Hyperkalemia and Ventricular Arrhythmia During Parathyroidectomy: A Case Report.
Rosenkrans DJ; Kolarczyk LM
A A Case Rep; 2017 Aug; 9(4):105-108. PubMed ID: 28622150
[TBL] [Abstract][Full Text] [Related]
7. A single-center experience of parathyroidectomy in 1500 cases for secondary hyperparathyroidism: a retrospective study.
Zhao S; Gan W; Xie W; Cao J; Zhang L; Wen P; Yang J; Xiong M
Ren Fail; 2022 Dec; 44(1):23-29. PubMed ID: 35094636
[TBL] [Abstract][Full Text] [Related]
8. Parathyroidectomy improves cardiovascular outcome in nondiabetic dialysis patients with secondary hyperparathyroidism.
Lin HC; Chen CL; Lin HS; Chou KJ; Fang HC; Liu SI; Hsu CY; Huang WC; Huang CW; Huang CK; Chang TY; Chang YT; Lee PT
Clin Endocrinol (Oxf); 2014 Apr; 80(4):508-15. PubMed ID: 24102421
[TBL] [Abstract][Full Text] [Related]
9. [Total parathyroidectomy in treatment of Sagliker syndrome in 10 cases of hemodialysing patients with secondary hyperparathyroidism].
Zhang L; Yao L; Hua Z; Bian WJ; Li WG
Zhonghua Nei Ke Za Zhi; 2011 Jul; 50(7):562-7. PubMed ID: 22041265
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal dialysis can alleviate the clinical course of hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism.
Yang G; Ge Y; Zha X; Mao H; Wang N; Xing C
Int Urol Nephrol; 2019 Mar; 51(3):535-542. PubMed ID: 30689179
[TBL] [Abstract][Full Text] [Related]
11. The high prevalence of alexithymia in hemodialyzed patients with secondary hyperparathyroidism unsuppressed by medical therapy is cured by parathyroidectomy.
De Santo RM; Livrea A; De Santo NG; Conzo G; Bilancio G; Celsi S; Cirillo M
J Ren Nutr; 2010 Sep; 20(5 Suppl):S64-70. PubMed ID: 20797574
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative and postoperative hyperkalaemia after total parathyroidectomy following exposure to cinacalcet in sixteen patients for renal hyperparathyroidism.
Chong GC; Choi JDW; Lee TT; Carney G
Clin Otolaryngol; 2017 Dec; 42(6):1369-1373. PubMed ID: 28371312
[No Abstract] [Full Text] [Related]
13. Effectiveness of cinacalcet in patients with recurrent/persistent secondary hyperparathyroidism following parathyroidectomy: results of the ECHO study.
Zitt E; Rix M; Ureña Torres P; Fouque D; Jacobson SH; Pétavy F; Dehmel B; Ryba M
Nephrol Dial Transplant; 2011 Jun; 26(6):1956-61. PubMed ID: 20947534
[TBL] [Abstract][Full Text] [Related]
14. [Indications and efficacy of parathyroidectomy in the treatment of secondary hyperparathyroidism in patients with chronic renal failure: our experience].
Cotellese R; Mariano F; Costantini R; Francomano F; Napolitano L
Chir Ital; 2004; 56(1):47-53. PubMed ID: 15038647
[TBL] [Abstract][Full Text] [Related]
15. Assessment of resource use and costs associated with parathyroidectomy for secondary hyperparathyroidism in end stage renal disease in the UK.
Pockett RD; Cevro E; Chamberlain G; Scott-Coombes D; Baboolal K
J Med Econ; 2014 Mar; 17(3):198-206. PubMed ID: 24279874
[TBL] [Abstract][Full Text] [Related]
16. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B
Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
[TBL] [Abstract][Full Text] [Related]
17. Total parathyroidectomy without autotransplantation in dialysis patients and renal transplant recipients, long-term follow-up evaluation.
Drakopoulos S; Koukoulaki M; Apostolou T; Pistolas D; Balaska K; Gavriil S; Hadjiconstantinou V
Am J Surg; 2009 Aug; 198(2):178-83. PubMed ID: 19217601
[TBL] [Abstract][Full Text] [Related]
18. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism.
Costa-Hong V; Jorgetti V; Gowdak LH; Moyses RM; Krieger EM; De Lima JJ
Surgery; 2007 Nov; 142(5):699-703. PubMed ID: 17981190
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome after total parathyroidectomy for the management of secondary hyperparathyroidism.
Stracke S; Keller F; Steinbach G; Henne-Bruns D; Wuerl P
Nephron Clin Pract; 2009; 111(2):c102-9. PubMed ID: 19142022
[TBL] [Abstract][Full Text] [Related]
20. The Risk of Peripheral Arterial Disease after Parathyroidectomy in Patients with End-Stage Renal Disease.
Hsu YH; Yu HY; Chen HJ; Li TC; Hsu CC; Kao CH
PLoS One; 2016; 11(6):e0156863. PubMed ID: 27284924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
